Anti-Inflammatory Drugs Market Size | 2021 Global Industry Forecast To 2026, is latest report on Global Anti-Inflammatory Drugs Industry, published by Fortune Business Insights. Report provides comprehensive information on Global Anti-Inflammatory Drugs Market and Impact of Covid-19 on Healthcare Industry. According to report Global market value of Anti-Inflammatory Drugs is to hit USD 191.42 billion value by 2026 at CAGR of 9.3%. Report segments Anti-Inflammatory Drugs Market By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids), By Application (Autoimmune Inflammatory Diseases (Rheumatoid Arthritis Psoriasis), Respiratory Diseases), By Route of Administration (Oral, Injection, Inhalation, and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), and Regional Forecast, 2020-2027
Major Anti-Inflammatory Drugs manufacturers are studied in this report for better understanding of global market scenario:
- Novartis AG
- AbbVie Inc.
- Biogen
- Merck & Co., Inc.
- Amgen Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Johnson & Johnson Services, Inc.
- GlaxoSmithKline plc.
- Pfizer Inc.
- Other Players
Get Sample Report Brochure Of Anti-Inflammatory Drugs Market at:
The global anti-inflammatory market size is expected to reach USD 191.42 billion by 2027 on account of increasing investments on the development of biologics for treating autoimmune inflammatory diseases. Anti-inflammatory drugs help to reduce inflammation in the body and treat health conditions such as arthritis, asthma, rheumatoid arthritis, sinusitis, and others. A recently published report by Fortune Business Insights offers a comprehensive overview of the market and its prime growth trajectories. As per the report titled, “Anti-Inflammatory Drugs Market Size, Share & Industry Analysis, By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids), By Application (Autoimmune Inflammatory Diseases (Rheumatoid Arthritis Psoriasis, and Others), Respiratory Diseases, and Others), By Route of Administration (Oral, Injection, Inhalation, and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027,” the value of the market was USD 93.88 billion in 2019 and is expected to rise at a CAGR of 9.3% between 2020 to 2027.
Increasing Prevalence of Inflammatory Diseases will Add Impetus to Market
The increasing prevalence of inflammatory diseases namely ulcerative colitis, inflammatory bowel, psoriasis, and rheumatoid arthritis, and others are the major anti-inflammatory drugs market growth driver. As per the Centers for Disease Control and Prevention, an estimate of 78 million people in the U.S. will be diagnosed with arthritis by the end of 2040. Apart from this, the increasing uptake of corticosteroids for treating chronic obstructive pulmonary diseases (COPD) and asthma, coupled with the increasing prevalence of atopic dermatitis are likely to aid in the expansion of the market in the long run.
The global pandemic, COVID-19, has led to severe repercussion owing to its widespread effects across several economies. Several industries are facing unprecedented losses owing to the lockdown announced by several governments across the globe that has resulted in the complete shutdown of the businesses. The crippling economy, however, is being revived through collective efforts from the government as well as the industries and is expected to bounce back in the coming years.
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Anti-Inflammatory Drugs Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.
Anti-Inflammatory Drugs Market report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.
Speak to Anti-Inflammatory Drugs Industry Analyst:
Competitive And Regional Analysis:
This report focuses on Anti-Inflammatory Drugs Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report.
North America to Emerge Dominant with Favorable Reimbursement Policies
Geographically, the market is dominated by North America with the rising demand for anti-inflammatory biologics, and government support for their launches. In 2019, North America earned a revenue of USD 41.39 billion, attributed to the massive investments in research and development that further expanded the regional market. The market in Europe, on the other hand, is likely to witness significant growth on account of active government support for launching biosimilars, and favorable health reimbursement policies. Moreover, the market in Asia Pacific will rise at a rapid speed on account of improving healthcare infrastructure and facilities, coupled with the increasing geriatric population, and rising preference for generic corticosteroids and NSAIDs. Furthermore, the Middle East and Latin American markets will gain momentum on account of the growing incidences of rheumatoid arthritis and improving healthcare infrastructure in the respective regions.
Anti-Inflammatory Drugs Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
Browse complete report information at:
https://www.fortunebusinessinsights.com/anti-inflammatory-drugs-market-102825
Key questions answered in the report:
- What are the opportunities & challenges for new entrants?
- Who are the prominent vendors present in the global market?
- Which segment would provide the most opportunity for market growth?
- Where will the current developments take the industry in the long term?
Table of Content:
1 Anti-Inflammatory Drugs Market Overview
1.1 Anti-Inflammatory Drugs Product Overview
1.2 Anti-Inflammatory Drugs Market Segment by Type
1.3 Global Anti-Inflammatory Drugs Market Size by Type (2015-2026)
1.3.1 Anti-Inflammatory Drugs Global Market Size Overview by Type (2015-2026)
1.3.2 Global Anti-Inflammatory Drugs Historic Market Size Review by Type (2015-2021)
1.3.2.1 Anti-Inflammatory Drugs Sales Global Market Share Breakdown by Type (2015-2026)
1.3.2.2 Anti-Inflammatory Drugs Global Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global Anti-Inflammatory Drugs Average Selling Price (ASP) by Type (2015-2026)
1.3.3 Anti-Inflammatory Drugs Market Size Forecast by Type (2021-2026)
1.3.3.1 Global Anti-Inflammatory Drugs Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global Anti-Inflammatory Drugs Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global Anti-Inflammatory Drugs Average Selling Price (ASP) by Application (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2021)
1.4.1 North America Anti-Inflammatory Drugs Sales Breakdown by Type (2015-2026)
1.4.2 Europe Anti-Inflammatory Drugs Sales Breakdown by Type (2015-2026)
1.4.3 Asia-Pacific Anti-Inflammatory Drugs Sales Breakdown by Type (2015-2026)
1.4.4 Latin America Anti-Inflammatory Drugs Sales Breakdown by Type (2015-2026)
1.4.5 Middle East and Africa Anti-Inflammatory Drugs Sales Breakdown by Type (2015-2026)
2 Global Anti-Inflammatory Drugs Market Competition by Company
2.1 Global Top Players by Anti-Inflammatory Drugs Sales (2015-2021)
2.2 Global Top Players by Anti-Inflammatory Drugs Revenue (2015-2021)
2.3 Global Top Players Anti-Inflammatory Drugs Average Selling Price (ASP) (2015-2021)
2.4 Global Top Company Anti-Inflammatory Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Inflammatory Drugs Market Competitive Situation and Trends
2.5.1 Anti-Inflammatory Drugs Market Growth Rate (2015-2021)
2.5.2 Global 5 and 10 Largest Company by Anti-Inflammatory Drugs Sales and Revenue in 2019
2.6 Global Anti-Inflammatory Drugs Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Inflammatory Drugs as of 2019)
2.7 Date of Key Company Enter into Anti-Inflammatory Drugs Market
2.8 Key Company Anti-Inflammatory Drugs Product Offered
2.9 Mergers and Acquisitions, Expansion
3 Global Anti-Inflammatory Drugs Status and Outlook by Region (2015-2026)
3.1 Global Anti-Inflammatory Drugs Market Size and CAGR by Region: 2015 VS 2021 VS 2026
3.2 Global Anti-Inflammatory Drugs Market Size Market Share by Region (2015-2021)
3.2.1 Global Anti-Inflammatory Drugs Sales Market Share by Region (2015-2021)
3.2.2 Global Anti-Inflammatory Drugs Revenue Market Share by Region (2015-2021)
3.2.3 Global Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2015-2021)
3.3 Global Anti-Inflammatory Drugs Market Size Market Share by Region (2021-2026)
3.3.1 Global Anti-Inflammatory Drugs Sales Market Share by Region (2021-2026)
3.3.2 Global Anti-Inflammatory Drugs Revenue Market Share by Region (2021-2026)
3.3.3 Global Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
3.4 North America Anti-Inflammatory Drugs Market Size By Growth (2015-2026)
3.4.1 North America Anti-Inflammatory Drugs Revenue By Growth (2015-2026)
3.4.2 North America Anti-Inflammatory Drugs Sales By Growth (2015-2026)
3.5 Asia-Pacific Anti-Inflammatory Drugs Market Size By Growth (2015-2026)
3.5.1 Asia-Pacific Anti-Inflammatory Drugs Revenue By Growth (2015-2026)
3.5.2 Asia-Pacific Anti-Inflammatory Drugs Sales By Growth (2015-2026)
3.6 Europe Anti-Inflammatory Drugs Market Size By Growth (2015-2026)
3.6.1 Europe Anti-Inflammatory Drugs Revenue By Growth (2015-2026)
3.6.2 Europe Anti-Inflammatory Drugs Sales By Growth (2015-2026)
3.7 Latin America Anti-Inflammatory Drugs Market Size By Growth (2015-2026)
3.7.1 Latin America Anti-Inflammatory Drugs Revenue By Growth (2015-2026)
3.7.2 Latin America Anti-Inflammatory Drugs Sales By Growth (2015-2026)
3.8 Middle East and Africa Anti-Inflammatory Drugs Market Size By Growth (2015-2026)
3.8.1 Middle East and Africa Anti-Inflammatory Drugs Revenue By Growth (2015-2026)
3.8.2 Middle East and Africa Anti-Inflammatory Drugs Sales By Growth (2015-2026)
4 Global Anti-Inflammatory Drugs by Application
4.1 Anti-Inflammatory Drugs Segment by Application
4.1.1 Residential
4.1.2 Commercial
4.2 Global Anti-Inflammatory Drugs Sales by Application: 2015 VS 2021 VS 2026
4.3 Global Anti-Inflammatory Drugs Historic Sales by Application (2015-2021)
4.4 Global Anti-Inflammatory Drugs Forecasted Sales by Application (2021-2026)
4.5 Key Regions Anti-Inflammatory Drugs Market Size by Application
4.5.1 North America Anti-Inflammatory Drugs by Application
4.5.2 Europe Anti-Inflammatory Drugs by Application
4.5.3 Asia-Pacific Anti-Inflammatory Drugs by Application
4.5.4 Latin America Anti-Inflammatory Drugs by Application
4.5.5 Middle East and Africa Anti-Inflammatory Drugs by Application
5 North America Anti-Inflammatory Drugs Market Size by Country (2015-2026)
5.1 North America Market Size Market Share by Country (2015-2021)
5.1.1 North America Anti-Inflammatory Drugs Sales Market Share by Country (2015-2021)
5.1.2 North America Anti-Inflammatory Drugs Revenue Market Share by Country (2015-2021)
5.2 North America Market Size Market Share by Country (2021-2026)
5.2.1 North America Anti-Inflammatory Drugs Sales Market Share by Country (2021-2026)
5.2.2 North America Anti-Inflammatory Drugs Revenue Market Share by Country (2021-2026)
5.3 North America Market Size By Growth by Country
5.3.1 U.S. Anti-Inflammatory Drugs Market Size By Growth (2015-2026)
5.3.2 Canada Anti-Inflammatory Drugs Market Size By Growth (2015-2026)
6 Europe Anti-Inflammatory Drugs Market Size by Country (2015-2026)
6.1 Europe Market Size Market Share by Country (2015-2021)
6.1.1 Europe Anti-Inflammatory Drugs Sales Market Share by Country (2015-2021)
6.1.2 Europe Anti-Inflammatory Drugs Revenue Market Share by Country (2015-2021)
6.2 Europe Market Size Market Share by Country (2021-2026)
6.2.1 Europe Anti-Inflammatory Drugs Sales Market Share by Country (2021-2026)
6.2.2 Europe Anti-Inflammatory Drugs Revenue Market Share by Country (2021-2026)
6.3 Europe Market Size By Growth by Country
6.3.1 Germany Anti-Inflammatory Drugs Market Size By Growth (2015-2026)
6.3.2 France Anti-Inflammatory Drugs Market Size By Growth (2015-2026)
6.3.3 U.K. Anti-Inflammatory Drugs Market Size By Growth (2015-2026)
6.3.4 Italy Anti-Inflammatory Drugs Market Size By Growth (2015-2026)
6.3.5 Russia Anti-Inflammatory Drugs Market Size By Growth (2015-2026)
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245